>>Natural Products>>Dehydroandrographolide succinate potassium sodium salt

Dehydroandrographolide succinate potassium sodium salt

Catalog No.GC35831

한약재인 Andrographis paniculata (Burm f) Nees에서 추출한 Dehydroandrographolide succinate(칼륨 나트륨염)는 면역 자극, 항감염 및 항염 효과로 인해 바이러스성 폐렴 및 바이러스성 상기도 감염의 치료에 널리 사용됩니다[1 ].

Products are for research use only. Not for human use. We do not sell to patients.

Dehydroandrographolide succinate potassium sodium salt Chemical Structure

Cas No.: 863319-40-8

Size 가격 재고 수량
1mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Dehydroandrographolide succinate (potassium sodium salt), extracted from herbal medicine Andrographis paniculata (Burm f) Nees, is widely used for the treatment of viral pneumonia and viral upper respiratory tract infections because of its immunostimulatory, anti-infective and anti-inflammatory effect[1][2].

[1]. Chen Q, et al. Pharmacokinetics and tolerance of dehydroandrographolide succinate injection after intravenousadministration in healthy Chinese volunteers. Acta Pharmacol Sin. 2012 Oct;33(10):1332-6. [2]. Xiaomeng Z, et al. Potassium dehydroandrographolide succinate injection for treat- ment of infantile pneumonia: a systematic review and Meta-analysis. J Tradit Chin Med. 2015 Apr;35(2):125-33.

리뷰

Review for Dehydroandrographolide succinate potassium sodium salt

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Dehydroandrographolide succinate potassium sodium salt

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.